Alan Burnett



Projects as PI
Go to first page Go to previous page 1 of 5 Go to next page Go to last page

Acute myeloid leukaemia or high risk myelodysplastic syndrome multi-site randomised trial - Funder:Genzyme Therapeutics Limited (27/02/2011 - 31/12/2011)
Acute Myeoild Leukaemia Trial (AML 15) Trial Grant - Funder:Medical Research Council (01/07/2002 - 31/12/2009)
AML 15 Trial Support Account - Funder:Wyeth Pharmaceuticals (01/07/2002 - 31/07/2010)


Projects as Co-Investigator
Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Cancer Genetics Biomedical Research Unit - Funder:Welsh Government (HCRW) (31/03/2011 - 31/05/2015)
CD200: A putative target of AML - Funder:Leukaemia Research Fund (01/12/2008 - 30/11/2011)
Clinical Hubs for phase 1 of the Cancer Research UK stratified medicine programme - Funder:Cancer Research UK (01/07/2011 - 31/12/2019)
Investigation of the role of RAL dysregulation in myeloid leukaemia - Funder:Leukaemia Research Fund (01/11/2008 - 31/10/2011)

Last updated on 2020-26-01 at 05:09